FlyteHealth Executive Board Chair, Dr. Cheryl Pegus, Co-Chair of newly launched Duke-Margolis Health Capital Impact Council

NEW CANAAN, Conn., March 27, 2025 /PRNewswire/ -- Cheryl Pegus, MD, MPH, Executive Board Chair of FlyteHealth, is Co-Chair of the newly launched Capital Impact Council at the Duke-Margolis Center for Health Policy. This groundbreaking initiative "supports the development of strategies, tools, and frameworks to enable the private investment community to demonstrate and deliver measurable benefits for health outcomes, access, affordability, and community resilience."

The Capital Impact Council (CIC) brings together venture capital and private equity investors along with Duke-Margolis Advisory Board Members to establish best practices for investments that lead to measurable improvements in the long-term health of communities. As a recognized leader in healthcare innovation and sustainable data-driven solutions, Dr. Pegus brings a wealth of expertise to the council.

"Private investment has enormous opportunity to drive innovation in health care, but to be truly transformative those investments must align with larger goals for affordability, sustainability, and long-term health outcomes," said Dr. Pegus. "I'm honored to help lead this council to create tools that make public-private partnerships more impactful."

Along with the announcement of the formation of the Council, the CIC issued "Health Value Return on Investment: A Framework to Support Private Investment that Improves Health Care and Health." This resource provides a framework for assessing and measuring the long-term ROI of health care innovations.  

To learn more about the Capital Impact Council, visit https://healthpolicy.duke.edu/CIC.

About FlyteHealth
FlyteHealth is obesity care that empowers you. Delivering a comprehensive suite of clinical care, technology, and support, FlyteHealth reduces the complexity and cost of obesity and its comorbid conditions for employers and payers. Based on the founders' decades of research and clinical care, FlyteHealth clinicians deliver the latest in personalized medication therapy and behavior coaching. The evidence-based treatment protocols enable individuals not only to lose weight and maintain weight loss long-term, but also to achieve significant improvements in outcomes related to diabetes, hypertension, heart disease, and many other weight-related health complications. Through the Flyte Intelligence obesity treatment platform, FlyteHealth empowers healthcare providers with subject matter expertise and care navigation services. Drawing from the largest data set of obesity and chronic disease research, Flyte Intelligence enables delivery of the highest standard of patient care at scale. For more information, please visit www.flytehealth.com.

SOURCE FlyteHealth